17 alpha-hydroxylase deficiency surgery: Difference between revisions
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{MJ}} | {{CMG}}; {{AE}} {{MJ}} | ||
==Overview== | ==Overview== | ||
The | Affected [[46,XY]] patients require gonadectomy to prevent malignant degeneration of [[testes]]. The reconstruction surgery for [[ambiguous genitalia]] in genetically male patients may be applied. | ||
==Surgery== | ==Surgery== | ||
Affected 46,XY patients require gonadectomy to prevent malignant degeneration of [[testes]]. The reconstruction surgery for [[ambiguous genitalia]] in genetically male patients may be applied.<ref name="pmid16882788">{{cite journal |vauthors=Lee PA, Houk CP, Ahmed SF, Hughes IA |title=Consensus statement on management of intersex disorders. International Consensus Conference on Intersex |journal=Pediatrics |volume=118 |issue=2 |pages=e488–500 |year=2006 |pmid=16882788 |doi=10.1542/peds.2006-0738 |url=}}</ref><ref name="pmid17875493">{{cite journal |vauthors=Looijenga LH, Hersmus R, Oosterhuis JW, Cools M, Drop SL, Wolffenbuttel KP |title=Tumor risk in disorders of sex development (DSD) |journal=Best Pract. Res. Clin. Endocrinol. Metab. |volume=21 |issue=3 |pages=480–95 |year=2007 |pmid=17875493 |doi=10.1016/j.beem.2007.05.001 |url=}}</ref> | Affected [[46,XY]] patients require gonadectomy to prevent malignant degeneration of [[testes]]. The reconstruction surgery for [[ambiguous genitalia]] in genetically male patients may be applied.<ref name="pmid16882788">{{cite journal |vauthors=Lee PA, Houk CP, Ahmed SF, Hughes IA |title=Consensus statement on management of intersex disorders. International Consensus Conference on Intersex |journal=Pediatrics |volume=118 |issue=2 |pages=e488–500 |year=2006 |pmid=16882788 |doi=10.1542/peds.2006-0738 |url=}}</ref><ref name="pmid17875493">{{cite journal |vauthors=Looijenga LH, Hersmus R, Oosterhuis JW, Cools M, Drop SL, Wolffenbuttel KP |title=Tumor risk in disorders of sex development (DSD) |journal=Best Pract. Res. Clin. Endocrinol. Metab. |volume=21 |issue=3 |pages=480–95 |year=2007 |pmid=17875493 |doi=10.1016/j.beem.2007.05.001 |url=}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 17:46, 7 August 2017
|
17 alpha-hydroxylase deficiency Microchapters |
|
Differentiating 17 alpha-hydroxylase deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency surgery On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency surgery |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Affected 46,XY patients require gonadectomy to prevent malignant degeneration of testes. The reconstruction surgery for ambiguous genitalia in genetically male patients may be applied.
Surgery
Affected 46,XY patients require gonadectomy to prevent malignant degeneration of testes. The reconstruction surgery for ambiguous genitalia in genetically male patients may be applied.[1][2]
References
- ↑ Lee PA, Houk CP, Ahmed SF, Hughes IA (2006). "Consensus statement on management of intersex disorders. International Consensus Conference on Intersex". Pediatrics. 118 (2): e488–500. doi:10.1542/peds.2006-0738. PMID 16882788.
- ↑ Looijenga LH, Hersmus R, Oosterhuis JW, Cools M, Drop SL, Wolffenbuttel KP (2007). "Tumor risk in disorders of sex development (DSD)". Best Pract. Res. Clin. Endocrinol. Metab. 21 (3): 480–95. doi:10.1016/j.beem.2007.05.001. PMID 17875493.